# Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease

*PRI Rank #9 · Topics and Trends in Most Cited Liver Disease Diagnosis and Treatment Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/liver-disease-diagnosis-and-treatment/2026/rank-9*

| Field | Value |
| --- | --- |
| Rank | #9 |
| 18m citations | 182 |
| Journal | Journal of Hepatology |
| Year | 2024 |
| DOI | 10.1016/j.jhep.2024.01.014 |
| Corresponding authors | Zobair M. Younossi |
| Institution | Inova Health System, United States |

**Ranking page:** [Topics and Trends in Most Cited Liver Disease Diagnosis and Treatment Papers, Class of 2026](https://pri.pepkio.com/top-papers/liver-disease-diagnosis-and-treatment/2026)

**Paper link:** [10.1016/j.jhep.2024.01.014](https://doi.org/10.1016/j.jhep.2024.01.014)

## Topics

Metabolic dysfunction-associated steatotic liver disease · Non-alcoholic fatty liver disease · clinical profiles · Mortality · Metabolic dysfunction-associated steatotic liver disease · Non-alcoholic fatty liver disease

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Liver Disease Diagnosis and Treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/liver-disease-diagnosis-and-treatment/2026. Accessed 2026-07-24.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```